Positron (OTCMKTS:POSC – Get Free Report) posted its earnings results on Friday. The company reported ($0.03) EPS for the quarter, Zacks reports. The company had revenue of $0.10 million during the quarter. Positron had a negative return on equity of 2,415.88% and a negative net margin of 2,279.55%.
Positron Stock Performance
Shares of OTCMKTS POSC traded down $0.05 during midday trading on Friday, hitting $1.64. 9,943 shares of the stock traded hands, compared to its average volume of 8,859. Positron has a one year low of $1.27 and a one year high of $2.74. The firm has a 50-day moving average of $1.73 and a two-hundred day moving average of $1.82. The firm has a market capitalization of $54.28 million, a P/E ratio of -5.12 and a beta of 0.67.
Positron Company Profile
Positron Corporation is a medical technology company focused on nuclear medicine and molecular imaging, with an emphasis on cardiac imaging. Its business centers on PET systems and related products and services used by healthcare providers in diagnostic imaging. The company’s product portfolio has included the Attrius PET scanner, a system designed specifically for cardiac applications. Cardiac PET imaging can help clinicians assess heart function and identify coronary artery disease. Positron serves the medical imaging market and has focused on expanding the use of PET technology in cardiology.
Read More
- Five stocks we like better than Positron
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Positron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Positron and related companies with MarketBeat.com's FREE daily email newsletter.
